Abstract
The dimeric dipeptide mimetic hexamethylenediamide bis-(N-monosuccinyl-L-asparaginyl-L-asparagine) (GTS-301) was created on the basis of the structure of the exposed region of the neurotrophin-3 4th loop. The new compound, as well as the full-length neurotrophin, activated the TrkC and TrkB receptors. GTS-301 showed neuroprotective activity in experiments on HT-22 mouse hippocampal cells under conditions of oxidative stress and glutamate toxicity at concentrations of 10–12 and 10–8 M, respectively, and antidepressant-like activity in the forced swimming test on mice with 7-day intraperitoneal administration in doses of 10–40 mg/kg.
Similar content being viewed by others
REFERENCES
Bothwell, M., NGF, BDNF, NT-3, and NT-4, Handb. Exp. Pharmacol., 2014, vol. 220, pp. 3–15.
de Miranda, A.S., de Barros J.L.V.M., and Teixeira, A.L., Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?, Expert Opin. Ther. Targets, 2020, vol. 24, no. 12, pp. 1225–1238.
Duricki, D.A., Drndarski, S., Bernanos, M., et al., Stroke recovery in rats after 24-hour-delayed intramuscular neurotrophin-3 infusion, Ann. Neurol., 2019, vol. 85, no. 1, pp. 32–46.
Shirayama, Y., Chen, A.C.-H., Nakagawa, S., et al., Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression, J. Neurosci., 2002, vol. 22, no. 8, pp. 3251–3261.
Pattarawarapan, M., Zaccaro, M.C., Saragovi, U.H., et al., New templates for syntheses of ring-fused, C(10) beta-turn peptidomimetics leading to the first reported small-molecule mimic of neurotrophin-3, J. Med. Chem., 2002, vol. 45, no. 20, pp. 4387–4390.
Kempfle, J.S., Duro, M.V., Zhang, A., et al., A novel small molecule neurotrophin-3 analogue promotes inner ear neurite outgrowth and synaptogenesis in vitro, Front. Cell. Neurosci., 2021, vol. 15, article ID 666706.
Zaccaro, M.C., Lee, H.B., Pattarawarapan, M., et al., Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities, Chem. Biol., 2005, vol. 12, no. 9, pp. 1015–1028.
Chen, D., Brahimi, F., Angell, Y., et al., Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals, ACS Chem. Biol., 2009, vol. 18, no. 4 (9), pp. 769–781.
Gudasheva, T.A., Ostrovskaya, R.U., and Seredenin, S.B., Novel technologies for dipeptide drugs design and their implantation, Curr. Pharm. Des., 2018, vol. 24, no. 26, pp. 3020–3027.
Gudasheva, T.A., Povarnina, P.Y., Tarasiuk, A.V., and Seredenin, S.B., Low-molecular mimetics of nerve growth factor and brain-derived neurotrophic factor: design and pharmacological properties, Med. Res. Rev., 2021, vol. 41, no. 5, pp. 2746–2774.
Logvinov, I.O., Antipova, T.A., Gudasheva, T.A., et al., Neuroprotective effects of dipeptide analogue of brain-derived neurotrophic factor GSB-106 in in vitro experiments, Bull. Exp. Biol. Med., 2013, vol. 155, no. 3, pp. 343–345.
Reichardt, L.F., Neurotrophin-regulated signalling pathways, Philos. Trans. R. Soc., B, 2006, vol. 361, no. 1473, pp. 1545–1564.
Gudasheva, T.A., Povarnina, P.Y., Antipova, T.A., Firsova, Y.N., Konstantinopolsky, M.A., and Seredenin, S.B., Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction, J. Biomed. Sci., 2015, vol. 8, no. 22, p. 106.
Ip, N.Y., Stitt, T.N., Tapley, P., et al., Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells, Neuron, 1993, vol. 10, no. 2, pp. 137–149.
Angoa- Pérez, M., Kane, M.J., Briggs, D.I., et al., Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype, ACS Chem. Neurosci., 2014, vol. 5, no. 10, pp. 908–919.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflicts of interest.
Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Additional information
Translated by M. Batrukova
Rights and permissions
About this article
Cite this article
Gudasheva, T.A., Sazonova, N.M., Tarasiuk, A.V. et al. The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties. Dokl Biochem Biophys 505, 160–165 (2022). https://doi.org/10.1134/S1607672922040032
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1607672922040032